The CD300e molecule in mice is an immune-activating receptor-Reference-Cited by-同舟云学术

The CD300e molecule in mice is an immune-activating receptor

Published:2018-03 Issue:10 Volume:293 Page:3793-3805
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Isobe Masamichi,Izawa Kumi,Sugiuchi Masahiro,Sakanishi Tamami,Kaitani Ayako,Takamori Ayako,Maehara Akie,Matsukawa Toshihiro,Takahashi Mariko,Yamanishi Yoshinori,Oki Toshihiko,Uchida Shino,Uchida Koichiro,Ando Tomoaki,Maeda Keiko,Nakano Nobuhiro,Yagita Hideo,Takai Toshiyuki,Ogawa Hideoki,Okumura Ko,Kitamura Toshio,Kitaura Jiro

Funder

MEXT Japan Society for the Promotion of Science (JSPS)

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference55 articles.

1. TREMs in the immune system and beyond;Colonna;Nat. Rev. Immunol,2003

2. Immune inhibitory receptors;Ravetch;Science,2000

3. C-type lectin receptors orchestrate antifungal immunity;Hardison;Nat. Immunol,2012

4. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation;Chung;J. Immunol,2003

5. Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation;Yotsumoto;J. Exp. Med,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD300e as a Driver of Immunosuppressive Tumor Microenvironment in Colorectal Cancer;2024-09-03

2. Exercise-downregulated CD300E acted as a negative prognostic implication and tumor-promoted role in pan-cancer;Frontiers in Immunology;2024-07-31

3. CD300e: Emerging role and mechanism as an immune-activating receptor;International Immunopharmacology;2024-05

4. Intranasal administration of ceramide liposome suppresses allergic rhinitis by targeting CD300f in murine models;Scientific Reports;2024-04-10

5. Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma;Scientific Reports;2024-02-16